Although intraneuronal GzmA staining was observed in both a PSP and a control brain, a more extensive analysis is required to determine the precise cellular and subcellular localisation of GzmA in the brain and whether there is greater colocalization of GzmA with tau in tauopathy compared with control brains. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.